Patent blue anaphylaxis: case report

J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):112-3. doi: 10.1016/j.jaip.2014.07.003. Epub 2014 Aug 29.

Authors

Leonor Paulos Viegas¹, Anabela Lopes², Alcinda Campos-Melo³, Manuel Branco Ferreira⁴, Manuel Pereira Barbosa⁴

Affiliations

¹ Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, E.P.E, Lisbon, Portugal. Electronic address: viegas.lp@gmail.com.
² Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, E.P.E, Lisbon, Portugal.
³ Clinical Immunology Laboratory, Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa- Universidade de Lisboa, Lisbon, Portugal.
⁴ Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, E.P.E, Lisbon, Portugal; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

PMID: 25577630
DOI: 10.1016/j.jaip.2014.07.003

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anaphylaxis / chemically induced*
Anaphylaxis / drug therapy
Anaphylaxis / immunology
Anti-Inflammatory Agents / therapeutic use
Bronchodilator Agents / therapeutic use
Epinephrine / therapeutic use
Female
Histamine Antagonists / therapeutic use
Humans
Hydrocortisone / therapeutic use
Hydroxyzine / therapeutic use
Intraoperative Complications / chemically induced*
Intraoperative Complications / immunology
Mastectomy
Methylprednisolone / therapeutic use
Middle Aged
Ranitidine / therapeutic use
Rosaniline Dyes / adverse effects*
Rosaniline Dyes / immunology

Substances

Anti-Inflammatory Agents
Bronchodilator Agents
Histamine Antagonists
Rosaniline Dyes
Hydroxyzine
Ranitidine
sulfan blue
Hydrocortisone
Methylprednisolone
Epinephrine